CANNELL & CO. – Regeneron Pharmaceuticals, Inc. Transaction History
CANNELL & CO. portfolio value:
$8.44M
portfolio value
CANNELL & CO. quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -0.27% | -33 shares | 1.17M | $688.87 | 12.25K |
Q2 2022 | share | Decrease | -1.62% | -202 shares | -1.45M | $591.13 | 12.28K |
Q1 2022 | share | Decrease | -0.52% | -65 shares | 794K | $698.42 | 12.49K |
Q4 2021 | share | Decrease | -4.09% | -535 shares | 7K | $642.51 | 12.55K |
Q3 2021 | share | Increase | 0.00% | 13.09K shares | 7.92M | $605.18 | 13.09K |
Q2 2021 | share | Decrease | -0.04% | -5 shares | 1.10M | $558.54 | 13.00K |
Q1 2021 | share | Decrease | -42.72% | -9.7K shares | -4.81M | $473.14 | 13.00K |
Q4 2020 | share | Increase | +71.43% | 9.46K shares | 3.55M | $483.11 | 22.70K |
Q3 2020 | share | Increase | +2.31% | 299 shares | -660K | $559.78 | 13.24K |
Q2 2020 | share | Decrease | -63.24% | -22.27K shares | -9.12M | $623.65 | 12.94K |
Q1 2020 | share | Decrease | -1.21% | -431 shares | 3.45M | $488.29 | 35.22K |
Q4 2019 | share | Increase | +202.25% | 23.85K shares | 10.47M | $375.48 | 35.65K |
Q3 2019 | share | Decrease | -29.71% | -4.98K shares | -1.98M | $277.4 | 11.79K |
Q2 2019 | share | Decrease | -55.79% | -21.17K shares | -10.33M | $313 | 16.78K |
Q1 2019 | share | Decrease | -15.32% | -6.86K shares | -1.15M | $410.62 | 37.95K |
Q4 2018 | share | Decrease | -2.26% | -1.03K shares | -1.78M | $373.5 | 44.82K |
Q3 2018 | share | Increase | +40.19% | 13.14K shares | 7.24M | $404.04 | 45.86K |
Q2 2018 | share | Increase | +3238.37% | 31.73K shares | 10.95M | $344.99 | 32.71K |
Q1 2018 | share | Increase | 0.00% | 980 shares | 337K | $344.36 | 980 |